Real-world treatment patterns among U.S. adults with unresectable hepatocellular carcinoma (uHCC) eligible for locoregional therapy (LRT).

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-01-27
DOI
https://doi.org/10.1200/jco.2025.43.4_suppl.547
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world treatment patterns among U.S. adults with unresectable hepatocellular carcinoma (uHCC) eligible for locoregional therapy (LRT).

Luke D. Bowden, Kasey Estenson, Leonid Dubrovsky, Kayla Hendrickson et al.
Journal of Clinical Oncology
Multiple and Secondary Primary Cancers
article

Real-world treatment patterns among U.S. adults with unresectable hepatocellular carcinoma (uHCC) eligible for locoregional therapy (LRT).

Luke D. Bowden, Kasey Estenson, Leonid Dubrovsky, Kayla Hendrickson, Karthik Ramakrishnan, Michael Fried, Leah Jackman, Abby B. Siegel, Shital Kamble, Kathleen E. Hurwitz
article en

Abstract

No abstract available for this paper.
Journal of Clinical OncologyVol. 43(4_suppl)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Target (United States) (US), Eisai (United States) (US)
Openalex Percentile: Top 98%
Multiple and Secondary Primary Cancers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.